Psychiatry AtlasMedication guide · United States

Medicine for selected movement problems

Benztropine (Cogentin)

Generic name
benztropine mesylate
Brand names
Cogentin
Medication class
Medicine for selected movement problems
Forms covered
Benztropine mesylate tablets; Benztropine mesylate injection

Article updated: 2026-10-30 · Sources last checked: 2026-11-05

Benztropine is an anticholinergic medicine used for parkinsonism and selected medication-induced movement problems. It is not a treatment for tardive dyskinesia and can make that condition worse.

Cogentin (historical brand).

What to expect: Benefit depends on identifying the movement problem correctly.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Adjunctive treatment of parkinsonism and selected drug-induced extrapyramidal movement disorders — Patients selected according to product labeling and movement diagnosis. Drug-induced parkinsonism and selected dystonic reactions must be distinguished from tardive dyskinesia and akathisia. This is not approval to treat an underlying psychiatric diagnosis.Benztropine mesylate tablets; Benztropine mesylate injection.

What should I expect?

Benefit depends on identifying the movement problem correctly. Benztropine can help some stiffness, shaking or acute muscle spasms caused by medication, but does not treat every abnormal movement.

Reassess the movement symptoms and ongoing need, along with memory, bowel and bladder function. Increasing the dose is not the right response to movements that may be tardive dyskinesia.

How do I take it safely?

Follow the oral prescription; injectable benztropine is administered by a clinician. The dose and duration depend on the specific movement problem. It is not a treatment for tardive dyskinesia and can worsen it.

Follow memory, vision, bowel and bladder function, sweating and heat tolerance. Avoid overheating and driving when thinking or vision is affected. Other anticholinergic medicines, including some allergy or sleep products, and alcohol or sedatives can add adverse effects.

Glaucoma, urinary obstruction and bowel problems need assessment. Children younger than 3 must not receive it under the selected label, and older adults are particularly prone to confusion and retention. Pregnancy and breastfeeding safety are not established.

Review whether ongoing treatment is needed and plan stopping with the clinician. For a missed dose, take it when remembered unless the next is near; never double.

Existing psychosis or memory impairment needs particular caution.

Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.

What side effects should I know about?

  • Dry mouth, constipation, blurred vision, nausea and dizziness.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Overheating with little sweating, severe confusion, high fever or collapse can be an emergency. Suspected overdose requires immediate emergency assessment.
  • Inability to urinate, sudden painful vision changes or a swollen painful abdomen needs urgent assessment. Fever with rigidity and altered awareness may be neuroleptic malignant syndrome; taking more benztropine is not its treatment.
  • Tardive dyskinesia can worsen. Report new or changing involuntary movements rather than increasing the dose yourself.

What else should I know to stay safe?

  • Do not use after product allergy or in children younger than 3. Older children also need caution because of the medicine’s effects on sweating, alertness and other body functions. Older age, memory problems, psychosis, glaucoma risk, bowel or urinary obstruction require particular caution.
  • Monitor memory, vision, bowel and bladder function and heat tolerance. Other anticholinergic medicines, including some sleep or allergy products, and alcohol or sedatives can add harm. Avoid overheating and driving when thinking or vision is affected.
  • Review continuing need and plan stopping with the clinician. Discuss pregnancy and breastfeeding because safety is not established.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Different movement side effects need different treatments. Benztropine can worsen tardive dyskinesia, even though it helps some other antipsychotic-related movement problems.
  • Dry mouth, constipation and thinking problems can add up across medicines, including nonprescription sleep or allergy products.

How does it work?

Benztropine reduces the effect of acetylcholine, a chemical messenger involved in movement and many other body functions. This can help with certain movement problems, including stiffness and shaking. It changes how cells respond to a message; it does not replace dopamine, another messenger involved in movement, or cure the underlying condition.

Explore more in Brain & Science: What Receptors and Transporters Do.

How was this medicine developed?

The original Cogentin tablet application was approved in 1954. Benztropine entered psychiatric practice for selected movement effects of other medicines, rather than as a treatment for psychosis itself.

How do I say the name?

Benztropine: BENZ-troe-peen. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Benztropine mesylate tablets: prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Clinical Pharmacology; Indications; Precautions; Adverse Reactions..

  2. Benztropine: original FDA application and historical product status
  3. Benztropine: patient information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Why is this medication prescribed?; Side effects..

  4. Benztropine mesylate: Hikma injectable product labeling

    Scope: United States; foreign scientific and safety context only.

  5. DailyMed - BENZTROPINE MESYLATE tablet
  6. Benztropine: Package Insert / Prescribing Information
  7. Benztropine: selected generic FDA approval and product status
  8. An evidence-based update on anticholinergic use for drug-induced movement disorders
  9. Benztropine mesylate injection: FDA approval and status
  10. Benztropine: curated stereochemistry and database cross-reference caution
  11. Bolden, Cusack and Richelson: Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Abstract: receptor-binding experiment..

  12. Tardive dyskinesia: MedlinePlus Medical Encyclopedia
  13. NIMH: Mental Health Medications
  14. A qualitative investigation into the effects of akathisia - Health Research Authority
  15. Extrapyramidal side effects- Management
  16. Anxiety and panic attacks - NHS
  17. Agitation: MedlinePlus Medical Encyclopedia
  18. NIMH: Understanding psychosis

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top